Enzyme inhibitor slows tumor growth

Enzyme inhibitor slows tumor growth

Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach for treating malignant tumors of the lymphatic system.

Comments are closed.

Rhombic lip implicated in origins of high-risk medulloblastoma
21 September 2022
Active screen time: New children’s app promotes healthy eating, exercise
21 September 2022